Bio LAB | 31 October 2024 | Company results
APAC Bullish on BioSupplier Revenue- Agilent
Agilent, USA Total revenue: $6,833 million APAC revenue: $1,383 million (China, including Hong Kong) ...Read more
Bio LAB | 31 October 2024 | Company results
APAC Bullish on BioSupplier Revenue- Eppendorf
Eppendorf AG, Germany Total revenue: $1,165 million (€1,081 million) APAC revenue: $356 million...Read more
Bio LAB | 31 October 2024 | Company results
APAC Bullish on BioSupplier Revenue- Shimadzu
Shimadzu Corporation, Japan Total revenue: $2.737 billion (410.6 billion Yen) APAC revenue: $2.0...Read more
Bio LAB | 31 October 2024 | Company results
APAC Bullish on BioSupplier Revenue- Waters Corp
Waters Corporation, USA Total revenue: $2.96 billion APAC revenue: $1.01 billion Waters...Read more
Bio LAB | 31 October 2024 | Company results
APAC Bullish on BioSupplier Revenue- Thermo Fisher Scientific
Thermo Fisher Scientific, USA Total revenue: $42.86 billion APAC revenue: $7,873 million Ther...Read more
Singapore | 18 October 2024 | News
BioSpectrum Asia sets the tone for Excellence Awards 2024 at Singapore on 6 December
To recognise and celebrate the remarkable achievements and contributions of Asian companies and individuals in...Read more
China | 26 September 2024 | News
Nuance Pharma expands distribution of nasal spray Bentrio in East and South East Asia
China-based Nuance Pharma has agreed with Altamira Medica, an associate company of Altamira Therapeutics ...Read more
Thailand | 23 September 2024 | News
Antengene receives approval to commercialise XPOVIO in Thailand for multiple myeloma patients
China-based Antengene Corporation has announced that the Thailand Food and Drug Administration has a...Read more
Japan | 05 September 2024 | News
US-based Rigel inks $162.5 M oncology deal with Kissei for Japan, Korea and Taiwan markets
US-based Rigel Pharmaceuticals, Inc., a commercial stage biotechnology company focused on hematologic disorder...Read more
Australia | 29 October 2024 | News
Australia's Vaxxas licenses next-gen vaccine for Respiratory Syncytial Virus from NIH
Australia-based Vaxxas, a clinical-stage biotechnology company commercialising a novel high-density micro...Read more
China | 10 October 2024 | News
China-based CanSino Biologics Inc. has received an additional financial boost, securing a grant exceeding $17 ...Read more
China | 27 September 2024 | News
Bayer opens new life science incubator in Shanghai Innovation Park, China
German pharmaceutical company Bayer has announced the inauguration of its new life science incubator, Bayer Co...Read more
Korea | 16 October 2024 | News
Korean firms Neurophet & AriBio to develop next-gen platform for Alzheimer's diagnosis
South Korea-based startup Neurophet, an artificial intelligence (AI) solution company for brain disease, has a...Read more
Indonesia | 10 October 2024 | News
Indonesia approves AI-assisted bone mineral density abnormalities screening software
Acer Medical, based in Taiwan, has announced that its artificial intelligence (AI)-assisted bone mineral densi...Read more
Taiwan | 26 September 2024 | News
Taiwan-based Flat Medical strengthens market leadership with acquisition of InjeQ assets
Taiwan-headquartered Flat Medical, a leading innovator in medical technology, has announced its acquisition of...Read more
China | 29 October 2024 | News
China's WuXi Biologics launches WuXia RidGS for non-antibiotic cell line development
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (C...Read more
Korea | 01 October 2024 | News
SK pharmteco invests $260 M in Korea facility to expand global small molecule and peptide production
US-headquartered SK pharmteco, a global contract development and manufacturing organisation (CDMO), has announ...Read more
Taiwan | 28 August 2024 | News
Taiwan-based Bora Pharmaceuticals Co. has announced that its Board of Directors has approved a strategic inves...Read more
APAC Bullish on Biosupplier Revenue Amidst Global Uncertainty
The Asia-Pacific (APAC) market plays a crucial role for global biosupplier companies, contributing anywhere from 15 per cent to 25 per cent of their total global revenues. Between 2021 and 2023, the bioprocessing market was one of the strongest performers, growing at about 18 per cent annually due to COVID-19-driven demand. However, 2023 was a challenging year for biosuppliers, with the decline in COVID-19-related spending and various global events impacting business, resulting in plummeting revenue for most firms. While the bioprocessing sector saw impressive growth between 2021 and 2022, post-COVID-19 normalisation and rising financing costs have led to flat growth from 2022 to 2023. Despite this, the market is expected to rebound over the next two years, with an average growth forecast of around 9 per cent from 2023 to 2027, according to a report from Clearstate.